- The Quirino Memorial Medical Center (QMMC) recently acquired the latest technology from BARD (a US-based medical solutions developer), for targeted temperature management.
- The hospital’s Center for Neurological Sciences (CNS), with the help of HealthSolutions Enterprises Inc., made the initiative which was readily embraced by the top management led by the Medical Center Chief, Dr. Evelyn Reside and the Chief of the Medical Professional Staff, Dr. Lino Santiago Pabillo.
This, to them, is part of QMMC’s commitment to deliver global standard practices and live by its identity as one of the brain centres in the country.
BARD Arctic Sun 5000 is a Targeted Temperature Management (TTM) system that is Safe, Precise and Reliable in targeting therapeutic treatments, both for hypothermia (bringing down patient’s core temperature to therapeutic level) or normothermia (maintaining the normal temperature of neurocritical patients with fever). Its touch screen interface quickly guides clinicians to successfully initiate treatments. It comes with an ARCTICGEL™ Pad which uses a water-based hydrogel that ensures surface contact and transfers energy effectively to the patient’s body.
According to QMMC’s Chief Medical Professional Staff Dr. Lino Santiago Pabillo, the hospital regularly accommodates a high volume of stroke patients. Because of this, there is a need for innovative equipment that will help their neurologists and nurses treat patients without compromise. With better control of the temperature of patients, the Arctic Sun is expected to improve the hospital’s current system for treating stroke.
CNS Chairman Dr. Maria Victoria G. Manuel expressed her delight during the product demonstration conducted by HealthSolutions Enterprises Inc. “In the past, we usually had to make-do and improvise with what we have”, she said. “With the help of the Arctic Sun 5000 by BARD, we now have a better way of cooling the body, which is crucial in improving chances of recovery and better outcomes for our patients.”
Dr. Jo Ann Soliven, the proponent and the centre’s stroke specialist believes that “this is a milestone in Philippine public health system’s emergency and intensive care delivery. It is a lifesaving, modern era therapeutic modality for saving brain tissue not only in post cardiac arrest but many critical neurologic cases such as severe stroke, traumatic brain injury and meningitis among others. It is already a standard of care in patients who have a return of spontaneous circulation (ROSC) after cardiac arrest (in or out of hospital). We have strong evidences that show how TTM helps improve outcomes in the above cases”.
In the Philippines, the BARD Arctic Sun 5000 is exclusively distributed by HealthSolutions Enterprises Inc. For more information about this product and acquisition, visit their official website at healthsolutions.com.ph/.
